View Cart
My AccountInfectious Disease Diagnostic Solutions
Microbix Phone+1803294983432Microbix Emailcustomer.service@microbix.com
Microbix Logo
Request Catalogue Contact Us
  • Services
    • Assay Development Solutions
    • Custom Vial Filling Services
  • Products
    • Reference Materials (QUANTDx™)
    • Antigens
      • All Antigens
      • Childhood Disease Antigens
      • Dengue Antigens
      • STI Antigens
      • ToRCH Antigens
      • Respiratory Antigens
      • Other Antigens
    • External Quality Controls (QAPs™)
      • All External QC Products
      • Respiratory Viral Panel
      • STI Panel
      • HPV Panel
      • Gastrointestinal Panel
      • Genital Ulcer Panel
      • Vaginal Infections Panel
      • ONBOARDx Kits
      • Proficiency Testing Panel
      • Technical Resources
    • DxTM™ Viral Transport Medium
    • Control Elution Buffer
    • Kinlytic (Urokinase)
  • About
    • Who We Are
    • Who We Work With
    • Quality
    • Board of Directors
    • Our Senior Team
    • Careers
  • Resources
    • White Papers
    • Poster Publication
    • Podcasts
  • Investors
    • News Releases
    • Financial Reports
    • Corporate Presentations
    • Analyst Coverage
    • Corporate Governance
    • Stock Information
Contact Us
Microbix Reports Results for Q2 Fiscal 2025

Microbix Reports Results for Q2 Fiscal 2025

by Aayat Punjabi | May 15, 2025 | Blog, Media Features News Releases, News Releases

Revenues of $5.3 million, Improved Gross Margin, and Positive Net Income   MISSISSAUGA, CANADA, May 15, 2025 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, reports results for its...
Microbix & Aurevia Introduce Novel EQA Scheme

Microbix & Aurevia Introduce Novel EQA Scheme

by Aayat Punjabi | May 13, 2025 | Blog, Media Features News Releases, News Releases

Pilot Program for Qualifying Clinical Labs to Diagnose Bacterial Vaginosis   MISSISSAUGA, CANADA & HELSINKI, FINLAND, May 13, 2025 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, and...
Microbix Schedules Release of Results for Q2 Fiscal 2025

Microbix Schedules Release of Results for Q2 Fiscal 2025

by Aayat Punjabi | May 8, 2025 | Blog, Media Features News Releases, News Releases

Results Release and Webinar Discussion on Morning of May 15, 2025   MISSISSAUGA, CANADA, May 8, 2025 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it expects to file the...
Microbix’s Clot-Buster Drug Project Advances

Microbix’s Clot-Buster Drug Project Advances

by Aayat Punjabi | May 5, 2025 | Blog, Media Features News Releases, News Releases

Sequel Pharma Executes Agreement with CDMO for Drug Product Manufacturing   MISSISSAUGA, CANADA, May 5, 2025 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that its funding and...
Microbix Presenting at the 2025 Bloom Burton Conference

Microbix Presenting at the 2025 Bloom Burton Conference

by Shitika Kulshreshtha | May 1, 2025 | Blog, Media Features News Releases, News Releases

Microbix Presenting at the 2025 Bloom Burton Conference   MISSISSAUGA, ONTARIO, May 1, 2025 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces it will be attending and presenting...
Microbix Exhibiting at ESCMID Global 2025

Microbix Exhibiting at ESCMID Global 2025

by Shitika Kulshreshtha | Apr 9, 2025 | Blog, Media Features News Releases, News Releases

Microbix Showcasing novel QAPs, Customer Presenting Pilot EQA Program Results   MISSISSAUGA, CANADA, April 9, 2025 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it will be...
« Older Entries
Next Entries »
  • Investors
  • Legal
  • Contact
  • News Releases
  • Accessibility
  • Careers
Microbix Funded By